MENU
BOLD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Boundless Bio (BOLD) Earnings Date & Reports
Boundless Bio Inc is a clinical-stage oncology company... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
BOLD is expected to report earnings to rise 35.00% to -81 cents per share on August 17
Q2'26
Est.
$-0.81
Q1'26
Beat
by $0.20
Q4'25
Beat
by $0.58
Q3'25
Beat
by $0.47
Q2'25
Beat
by $0.32
The last earnings report on May 08 showed earnings per share of -60 cents, beating the estimate of -80 cents. With 29.77M shares outstanding, the current market capitalization sits at 31.45M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of gene therapy products for patients with serious rare diseases
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
10955 Alexandria Way
Phone
+1 858 766-9912
Employees
28
Web
https://www.boundlessbio.com